NantKwest, Inc. (72) | Note Agreements (16)
Recent Contracts
-
Promissory Note between the Company and Nant Capital, LLC dated December 12, 2022
(Filed With SEC on December 12, 2022)
-
Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantWorks, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantCancerStemCell, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantMobile, LLC dated August 31, 2022
(Filed With SEC on November 9, 2022)
-
Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021
(Filed With SEC on December 20, 2021)
-
Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC
(Filed With SEC on March 10, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC
(Filed With SEC on January 19, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC
(Filed With SEC on January 19, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC
(Filed With SEC on January 19, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC
(Filed With SEC on January 19, 2021)
-
Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC
(Filed With SEC on January 19, 2021)